Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Edwards Lifesciences
(NY:
EW
)
71.27
+0.79 (+1.12%)
Official Closing Price
Updated: 7:00 PM EST, Nov 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Edwards Lifesciences
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
2 Top Dividend Growth Stocks to Buy in February
February 01, 2023
They don't offer the highest yields, but these strongly profitable businesses are poised to raise their payouts at a blistering pace.
Via
The Motley Fool
Edwards Lifesciences Stock Jumps After Beating Fourth-Quarter Views
January 31, 2023
The company expects full-year sales to grow 9%-12% in constant currency.
Via
Investor's Business Daily
Here's How Much $1000 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth Today
January 31, 2023
Via
Benzinga
Amazon To Rally Around 29%? Here Are 10 Other Analyst Forecasts For Monday
January 30, 2023
Barclays cut the price target for Amazon.com, Inc. (NASDAQ: AMZN) from $140 to $130. Barclays analyst Ross Sandler maintained an Overweight rating. Amazon shares fell 1.2% to $101.06 in pre-market...
Via
Benzinga
2 Smartest Tech Stocks to Buy in 2022 and Beyond
December 20, 2022
The tech space is still bursting with opportunities for long-term investors.
Via
The Motley Fool
Expert Ratings for Edwards Lifesciences
November 28, 2022
Via
Benzinga
15 Analysts Have This to Say About Edwards Lifesciences
November 28, 2022
Via
Benzinga
Why Edwards Lifesciences Stock Crashed 16% Today
October 28, 2022
Did investors overreact to the company's miss?
Via
The Motley Fool
Earnings Scheduled For January 31, 2023
January 31, 2023
Companies Reporting Before The Bell • Biophytis (NASDAQ:BPTS) is projected to report earnings for its first quarter.
Via
Benzinga
What 8 Analyst Ratings Have To Say About Edwards Lifesciences
January 30, 2023
Via
Benzinga
A Preview Of Edwards Lifesciences's Earnings
January 30, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 30, 2023
January 30, 2023
Via
Benzinga
Jim Cramer Recommends These 5 Healthcare Stocks For 2023: 'Biggest Winners Were Boring, Consistent Operators'
December 16, 2022
Prominent market commentator Jim Cramer has recommended five healthcare stocks which he believes should be on investors’ shopping list for 2023.
Via
Benzinga
JPMorgan To Rally Around 17%? Here Are 10 Other Price Target Changes For Tuesday
December 06, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022
December 06, 2022
Via
Benzinga
Reata Pharmaceuticals To Jump 220%? Plus JP Morgan Predicts $51 For Las Vegas Sands
November 28, 2022
Goldman Sachs boosted the price target on Reata Pharmaceuticals, Inc. (NASDAQ: RETA) from $86 to $115. Goldman Sachs analyst Madhu Kumar maintained the stock with a Buy rating. Reata Pharmaceuticals...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 2, 2022
December 02, 2022
Via
Benzinga
S&P 500 Component DexCom Set For Further Price, Earnings Growth
November 13, 2022
Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023.
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
Edwards Life Sciences Stock Disaster Could Be Your Bounty
November 07, 2022
Heart disease equipment maker Edwards Life Sciences (NYSE: EW) stock has fallen (-46%) on the year after a disastrous reaction to its Q3 2022 earnings report.
Via
MarketBeat
Topics
Death
Exposures
COVID-19
Death
Cramer's Take On This Stock That's Down 53% Year-To-Date: 'I Think Long-Term. I Don't Want To Own It'
November 03, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Cerence Inc. (NASDAQ: CRNC) can fall to $13, $12 in a market like this. "If you can take that level of pain, you can absolutely buy it, because it...
Via
Benzinga
7 Stocks to Buy at the ‘Midterm Elections’ Bottom
October 31, 2022
With the market tending to react positively to midterm election cycles, now may be a time to consider certain stocks to buy.
Via
InvestorPlace
Honeywell To $194? Plus Citigroup Slashes PT On This Stock By Over 93%
October 31, 2022
Daiwa Capital slashed the price target on Honeywell International Inc. (NYSE: HON) from $206 to $194. Honeywell shares fell 0.6% to $203.79 in pre-market trading.
Via
Benzinga
Weibo, XPeng, Li Auto And Other Big Losers From Friday
October 31, 2022
U.S. stocks closed higher on Friday, with the Dow Jones gaining more than 800 points. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday
October 31, 2022
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday.
Via
Benzinga
Nasdaq Climbs 275 Points; S&P 500 Rises Over 2%
October 28, 2022
U.S. stocks extended gains toward the end of trading, with the Nasdaq Composite surging more than 200 points on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 28, 2022
Gainers
Via
Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today
October 28, 2022
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 5 years by 7.47% on an annualized basis producing an average annual return of 15.86%. Currently, Edwards Lifesciences has a...
Via
Benzinga
Economic Challenges Hit Edwards Lifesciences Q3 Earnings, Guidance Lags Wall Street Estimates
October 28, 2022
Via
Benzinga
Dow Jumps 600 Points; Crude Oil Down Over 1%
October 28, 2022
U.S. stocks extended gains midway through trading, with the Dow Jones surging more than 600 points on Friday.
Via
Benzinga
Why Edwards Lifesciences Shares Are Trading Lower By Around 17%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
October 28, 2022
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) surged 179% to $3.6301.
Via
Benzinga
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.